invivo therapeutics stock price target

Invivo Therapeutics current and average target prices are 033 and 3754 respectively. Intellia Therapeutics NASDAQNTLA Get Rating had its price target cut by investment analysts at JMP Securities from 16500 to 11000 in a note issued to investors on Monday The Fly reports.

Invivo Therapeutics Holdings Corp Common Stock Nviv Stock Price Quote News History Nasdaq

Invivo Therapeutics Holdings Corps variance in analysts estimates is less than almost 100 of all US stocks.

. NVIV InVivo Therapeutics Holdings Corp Stock Price and Discussion Stocktwits. InVivo Therapeutics Holdings Corp. 1 year ago - Business Wire InVivo Therapeutics Announces Presentation at the Upcoming HC Wainwright Virtual Global Investment Conference.

During the day the stock fluctuated 1011 from a day low at 022 to a day high of 024. USD 036 001 286. Invivo Therapeutics stock price prediction is an act of determining the future value of Invivo Therapeutics shares using few different conventional methods such as EPS estimation analyst consensus or fundamental intrinsic valuation.

Competitors Stock Price Forecast The 1 analysts offering 12-month price forecasts for InVivo Therapeutics Holdings Corp have a median target of 93750. News InVivo Therapeutics Holdings Corp. And has now fallen 3 days in a row.

Analyst Price Target for NVIV i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. 0646 EUR upside and 0551 EUR downside. NVIV has a greater average analyst price target than 7821 of stocks in the small market cap category.

NVIV today announced the closing of its previously announced public offering of 18750000 shares of its common stock or. No significant news for NVIV in the past two years. The price has fallen in 5 of the last 10 days and is down by -307 for this period.

A high-level overview of InVivo Therapeutics Holdings Corp. 1 day and results in a price target of 035. The successful prediction of Invivo Therapeutics future price could yield a significant.

CAMBRIDGE Mass-- BUSINESS WIRE--InVivo Therapeutics Holdings Corp. InVivo Therapeutics Price Target Predictions Analyst Ratings 030 -004 -1227 As of 04142022 0655 PM ET Todays Range 030 036 50-Day Range 027 037 52-Week Range 026 093 Volume 584200 shs Average Volume 519217 shs Market Capitalization 1031 million PE Ratio NA Dividend Yield NA Beta 109 Profile Chart. Highest and lowest possible predicted price in a 14 day period.

InVivo Therapeutics Holdings Corp. Key Stock Data PE Ratio TTM NA EPS TTM -030 Market Cap 1031 M Shares Outstanding 3426 M Public. InVivo Therapeutics Holdings Corp NASDAQ Updated Mar 23 2022 941 PM.

Jan 20 New 90-day high. Each analysts rating is normalized to a standardized rating. Said Thursday it will carry out a 1-for-25 reverse stock split which is intended to increase the per-share trading price of its stock and fulfill the Nasdaq.

Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. On the other hand Invivo Therapeutics target price is what analysts think the stock is worth or could sell for in the future. Invivo Therapeutics current and average target prices are 033 and 3754 respectively.

10 hours agoCredit Suisse Group lifted their price target on Fulcrum Therapeutics from 3000 to 3500 and gave the stock an outperform rating in a research note on Friday March 25th. The forecast for the further price development based on current price information is 708 time horizon. InVivo Therapeutics 02171 00021 098 General Chart News Analysis Financials Technical Forum Technical Analysis Candlestick Patterns Analyst Price Target NVIV Analyst Price Target 1.

InVivo Therapeutics Stock Forecast Price News 526 -015 -277 As of 0562022 1200 AM ET Todays Range 521 552 50-Day Range 488 925 52-Week Range 471 2319 Volume 9498 shs Average Volume 23031 shs Market Capitalization 721 million PE Ratio NA Dividend Yield NA Beta 126 Profile Chart Competitors Earnings. InVivo Therapeutics Holdings stock price has been showing a declining tendency so we believe that similar market segments were not. InVivo Therapeutics Holdings stock price forecast for tomorrow and next weeks based on the last 30 days 04IC forecast for the upcoming days 04IC Target Price 04IC price target in 14 days.

Analyst ratings historical stock prices earnings estimates actuals. As of 2022 April 23 Saturday current price of NVIV stock is 0220 and our data indicates that the asset price has been in a downtrend for the past 1 year or since its inception. NVIV updated stock price target summary.

NVIV has a higher upside potential average analyst target price relative to current price than 9961 of Healthcare stocks. That means the average analyst price target for NVIV stock is 3750. About the Invivo Therapeutics Holdings Corp.

The last closing price of the INVIVO THERAPEUTICS HOLDINGS CORP share was 033 and has changed by 535 since the penultimate trading day. The company is up 196 from its price of US057 on 11 November 2020. Stock price fell by -407 on the last day Thursday 21st Apr 2022 from 024 to 023.

The current price of Invivo Therapeutics is the price at which Invivo Therapeutics Holdings is currently trading. The prediction is based on 1 analyst estimates. The InVivo Therapeutics Holdings Corp.

The American market is up 15 over the last 90 days indicating the company outperformed over that time. Profile Charts Financials Historical Quotes Analyst Estimates Options Snapshot Stock Price Targets Yearly Numbers Estimates NVIV will report 2019 earnings on 03012023 EPS Estimate 2021 2019 2020. Based on NVIV analyst price targets NVIV stock forecast is 3750 for a year from now.

The low price target for NVIV is 3750 while the high price target is 3750. NVIV 034 001 311 Post-Market 001 179 14642. It also outperformed the Medical Equipment industry which is up 90 over the same period.

NVIV analyst rating is Strong Buy.

Nviv Stock Price And Chart Nasdaq Nviv Tradingview